» Authors » J A Abbott

J A Abbott

Explore the profile of J A Abbott including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 774
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aherne M, Borgarelli M, Menciotti G, Lahmers S, Abbott J
J Vet Cardiol . 2024 Sep; 56:8-22. PMID: 39278151
Introduction/objectives: To compare conventional and three-dimensional (3D) echocardiographic indices of right ventricular (RV) systolic function in dogs with various stages of myxomatous mitral valve disease (MMVD), classified according to the...
2.
Li F, Abbott J
Climacteric . 2023 Oct; 26(6):638. PMID: 37782251
No abstract available.
3.
Franchini A, Borgarelli M, Abbott J, Menciotti G, Crosara S, Haggstrom J, et al.
J Vet Cardiol . 2022 Mar; 41:99-120. PMID: 35316716
Objectives: To describe the medical treatment prescribed or modified by veterinary cardiologists at the enrollment visit in dogs included in the longitudinal outcome of canine (K9) myxomatous mitral valve disease...
4.
Lawson P, Abbott J
J Vet Cardiol . 2021 Jul; 36:186-190. PMID: 34304107
A 10-year-old female Labrador retriever was presented for evaluation and management of syncope. On presentation, idioventricular tachycardia (IT) was electrocardiographically evident but neither ventricular capture nor fusion complexes were recorded....
5.
Franchini A, Borgarelli M, Abbott J, Menciotti G, Crosara S, Haggstrom J, et al.
J Vet Cardiol . 2021 Jun; 36:32-47. PMID: 34062479
Introduction: The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (MMVD) registry (LOOK-Mitral registry) was established to describe the natural history and predictors of outcome in dogs affected by...
6.
Menciotti G, Abbott J, Aherne M, Lahmers S, Borgarelli M
J Vet Cardiol . 2021 Apr; 35:90-100. PMID: 33895627
Introduction: Echocardiographically identified pulmonary hypertension is an independent predictor of poor outcome in dogs affected by myxomatous valvular degeneration (MMVD). Systolic pulmonary arterial pressure is routinely estimated based on its...
7.
Franchini A, Abbott J, Tyrrell W, Rosenthal S, Lahmers S, Menciotti G, et al.
J Vet Cardiol . 2021 Mar; 34:112-119. PMID: 33706221
Introduction: Myxomatous mitral valve disease (MMVD) is the most common cause of left-sided congestive heart failure in dogs. We sought to identify predictors of first reoccurrence of congestive signs (CS)...
8.
Rowlands I, Abbott J, Montgomery G, Hockey R, Rogers P, Mishra G
BJOG . 2020 Aug; 128(4):657-665. PMID: 32757329
Objective: To estimate the prevalence and incidence of endometriosis among Australian women. Design: Population-based cohort study linked to administrative health records. Setting: Secondary analysis of seven surveys collected between 2000...
9.
Nesbitt-Hawes E, Dietz H, Abbott J
Ultrasound Obstet Gynecol . 2018 Apr; 52(5):672-676. PMID: 29700879
Objectives: To describe morphometry of the pelvic floor in a large population of nulliparous women, comparing those with and those without pelvic pain. We also aimed to assess its association...
10.
Boswood A, Gordon S, Haggstrom J, Wess G, Stepien R, Oyama M, et al.
J Vet Intern Med . 2017 Dec; 32(1):72-85. PMID: 29214723
Background: Changes in clinical variables associated with the administration of pimobendan to dogs with preclinical myxomatous mitral valve disease (MMVD) and cardiomegaly have not been described. Objectives: To investigate the...